Executive Retina Program Director, Phase 1 Gene Therapy

Scorpion Therapeutics; United States; On-site; USD 250,000 - 360,000; Full time

Job summary

Scorpion Therapeutics seeks an Executive Medical Director to oversee Phase 1 ophthalmology trials focused on retinal diseases, including wet age-related macular degeneration and diabetic macular edema. You will lead study design, safety oversight, and first-in-human clinical readouts.

Reporting to the CMO with a dotted line to the SVP of Research & Early-Stage Product Development, you will manage cross-functional teams, develop biomarker strategies, and drive regulatory submissions and external

Qualifications

• MD with ophthalmology residency and retina subspecialty.
• 10+ years of clinical ophthalmology research in biopharma.
• Expertise in Phase 1 trials, gene therapy, and regulatory submissions.
• Knowledge of ICH-GCP and FDA guidelines.
• Excellent communication skills.

Responsibilities

• Leading study design
• Safety oversight
• Data analysis and clinical readouts
• Managing cross-functional teams (clinical operations, biometrics, regulatory, CMC)
• Developing biomarker strategies
• Authoring regulatory documents
• Engaging with external stakeholders

Skills

Phase 1 trials expertise

Regulatory submissions experience

ICH-GCP FDA guidelines knowledge

Excellent communication skills

Education

MD

Ophthalmology residency with retina subspecialty

Job description

Scorpion Therapeutics seeks an Executive Medical Director to oversee Phase 1 ophthalmology trials focused on retinal diseases, including wet age-related macular degeneration and diabetic macular edema. You will lead study design, safety oversight, and first-in-human clinical readouts.

Reporting to the CMO with a dotted line to the SVP of Research & Early-Stage Product Development, you will manage cross-functional teams, develop biomarker strategies, and drive regulatory submissions and external